Search Results

There are 6371 results for: content related to: Diabetes mellitus and periodontal disease

  1. The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 2, February 2011, Pages: 169–180, D. Singh-Franco, A. Perez and C. Harrington

    Version of Record online : 27 DEC 2010, DOI: 10.1111/j.1463-1326.2010.01337.x

  2. Pharmacokinetics of an Oral Drug (Acetaminophen) Administered at Various Times Relative to Subcutaneous Injection of Pramlintide in Subjects With Type 2 Diabetes

    The Journal of Clinical Pharmacology

    Volume 47, Issue 7, July 2007, Pages: 798–805, Dr Terrie A. Kellmeyer, Dr Nicole C. Kesty, Dr Yan Wang, Dr Juan P. Frias and Mr Mark S. Fineman

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007300949

  3. Adjunctive Therapy with Pramlintide in Patients with Type 1 or Type 2 Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 11, November 2006, Pages: 1626–1640, Dr. Anna Nogid and Dr. David Q. Pham

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.11.1626

  4. You have free access to this content
    Effect of Pramlintide on Weight in Overweight and Obese Insulin-Treated Type 2 Diabetes Patients

    Obesity Research

    Volume 12, Issue 4, April 2004, Pages: 661–668, Priscilla Hollander, David G. Maggs, James A. Ruggles, Mark Fineman, Larry Shen, Orville G. Kolterman and Christian Weyer

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2004.76

  5. Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin

    Drug Development Research

    Volume 37, Issue 4, April 1996, Pages: 231–248, Andrew A. Young, William Vine, Bronislava R. Gedulin, Richard Pittner, Susan Janes, Laura S.L. Gaeta, Amy Percy, Candace X. Moore, Joy E. Koda, Timothy J. Rink and Kevin Beaumont

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M

  6. You have free access to this content
    Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial

    Obesity

    Volume 18, Issue 9, September 2010, Pages: 1739–1746, Louis J. Aronne, Amy E. Halseth, Colleen M. Burns, Stephan Miller and Larry Z. Shen

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2009.478

  7. You have free access to this content
    Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy

    Obesity

    Volume 17, Issue 9, September 2009, Pages: 1736–1743, Eric Ravussin, Steven R. Smith, Julie A. Mitchell, Reshma Shringarpure, Kevin Shan, Holly Maier, Joy E. Koda and Christian Weyer

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2009.184

  8. You have free access to this content
    Low-dose Pramlintide Reduced Food Intake and Meal Duration in Healthy, Normal-Weight Subjects

    Obesity

    Volume 15, Issue 5, May 2007, Pages: 1179–1186, Ian Chapman, Barbara Parker, Selena Doran, Christine Feinle-Bisset, Judith Wishart, Cameron W. Lush, Kim Chen, Carl LaCerte, Colleen Burns, Robyn McKay, Christian Weyer and Michael Horowitz

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.626

  9. You have full text access to this OnlineOpen article
    Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 9, September 2015, Pages: 904–907, M. C. Riddle, K. C. J. Yuen, T. W. de Bruin, K. Herrmann, J. Xu, P. Öhman and O. G. Kolterman

    Version of Record online : 8 JUL 2015, DOI: 10.1111/dom.12504

  10. Amylin and Glycaemic Regulation: a Possible Role for the Human Amylin Analogue Pramlintide

    Diabetic Medicine

    Volume 14, Issue S2, June 1997, Pages: S35–S38, O.G. Kolterman

    Version of Record online : 19 JUL 2004, DOI: 10.1002/(SICI)1096-9136(199706)14:2+<S35::AID-DIA402>3.0.CO;2-8

  11. Novel therapies for the management of type 2 diabetes mellitus: Part 1. Pramlintide and bromocriptine-QR (2型糖尿病治疗新药:第1部分.普兰林肽与溴隐亭-QR)

    Journal of Diabetes

    Volume 5, Issue 2, June 2013, Pages: 110–117, George Grunberger

    Version of Record online : 26 APR 2013, DOI: 10.1111/1753-0407.12034

  12. Pramlintide in the treatment of diabetes

    International Journal of Clinical Practice

    Volume 60, Issue 12, December 2006, Pages: 1647–1653, S. V. EDELMAN, T. DARSOW and J. P. FRIAS

    Version of Record online : 10 NOV 2006, DOI: 10.1111/j.1742-1241.2006.01187.x

  13. Pramlintide: A Human Amylin Analogue Reduced Postprandial Plasma Glucose, Insulin, and C-peptide Concentrations in Patients with Type 2 Diabetes

    Diabetic Medicine

    Volume 14, Issue 7, July 1997, Pages: 547–555, R.G. Thompson, A. Gottlieb, K. Organ, J. Koda, J. Kisicki and O.G. Kolterman

    Version of Record online : 19 JUL 2004, DOI: 10.1002/(SICI)1096-9136(199707)14:7<547::AID-DIA390>3.0.CO;2-U

  14. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus

    Neurogastroenterology & Motility

    Volume 14, Issue 2, April 2002, Pages: 123–131, A. VELLA, J. S. LEE, M. CAMILLERI, L. A. SZARKA, D. D. BURTON, A. R. ZINSMEISTER, R. A. RIZZA and P. D. KLEIN

    Version of Record online : 26 APR 2002, DOI: 10.1046/j.1365-2982.2002.00311.x

  15. The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes

    Diabetes, Obesity and Metabolism

    Volume 7, Issue 5, September 2005, Pages: 504–516, S. A. Amiel, S. R. Heller, I. A. Macdonald, S. L. Schwartz, L. J. Klaff, J. A. Ruggles, C. Weyer, O. G. Kolterman and D. G. Maggs

    Version of Record online : 2 DEC 2004, DOI: 10.1111/j.1463-1326.2004.00417.x

  16. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

    Diabetic Medicine

    Volume 21, Issue 11, November 2004, Pages: 1204–1212, R. E. Ratner, R. Dickey, M. Fineman, D. G. Maggs, L. Shen, S. A. Strobel, C. Weyer and O. G. Kolterman

    Version of Record online : 20 OCT 2004, DOI: 10.1111/j.1464-5491.2004.01319.x

  17. You have free access to this content
    Safety of pramlintide added to mealtime insulin in patients with type 1 or type 2 diabetes: a large observational study

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 6, June 2010, Pages: 548–551, R. Pencek, T. Roddy, Y. Peters, M. B. De Young, K. Herrmann, L. Meller, H. Nguyen, S. Chen and K. Lutz

    Version of Record online : 13 JAN 2010, DOI: 10.1111/j.1463-1326.2010.01201.x

  18. Reducing postprandial hyperglycemia with adjuvant premeal pramlintide and postmeal insulin in children with type 1 diabetes mellitus

    Pediatric Diabetes

    Volume 10, Issue 4, June 2009, Pages: 264–268, Krishnavathana Hassan and Rubina A Heptulla

    Version of Record online : 18 DEC 2008, DOI: 10.1111/j.1399-5448.2008.00490.x

  19. Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1

    Diabetic Medicine

    Volume 19, Issue 9, September 2002, Pages: 790–792, B. Ahrén, N. Adner, J. Svartberg, E. Petrella, J. J. Holst and M. K. Gutniak

    Version of Record online : 6 SEP 2002, DOI: 10.1046/j.1464-5491.2002.00657_1.x

  20. Glycosylation of Pramlintide: Synthetic Glycopeptides that Display In Vitro and In Vivo Activities as Amylin Receptor Agonists

    Chemistry - A European Journal

    Volume 19, Issue 45, November 4, 2013, Pages: 15084–15088, Dr. Yusuke Tomabechi, Dr. Guy Krippner, Dr. Phillip M. Rendle, Dr. Marie A. Squire and Prof. Antony J. Fairbanks

    Version of Record online : 7 OCT 2013, DOI: 10.1002/chem.201303303